Commodore Capital LP: 13F holdings
CIK 18319422026Q2
| Positions | 33 |
|---|
| Reported value | $1.7bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 33 (-3 vs prior quarter) |
|---|
| Reported value | $1.7bn (-2.9%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| RLAY RELAY THERAPEUTICS INC | 12,000,000 | $224.5m | 13.4% |
| ELVN ENLIVEN THERAPEUTICS INC | 3,275,000 | $166.2m | 9.9% |
| ALKERMES PLC | 3,000,000 | $157.2m | 9.4% |
| COGT COGENT BIOSCIENCES INC | 3,050,000 | $118.0m | 7.0% |
| AMLX AMYLYX PHARMACEUTICALS INC | 5,650,000 | $101.5m | 6.0% |
| DFTX DEFINIUM THERAPEUTICS INC | 2,000,000 | $94.1m | 5.6% |
| SYRE SPYRE THERAPEUTICS INC | 846,786 | $75.2m | 4.5% |
| ANRO ALTO NEUROSCIENCE INC | 2,723,196 | $71.9m | 4.3% |
| TNGX TANGO THERAPEUTICS INC | 2,250,000 | $70.3m | 4.2% |
| EYPT EYEPOINT INC | 4,600,000 | $65.8m | 3.9% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1831942")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples